| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 21.43T | 21.69T | 20.43T | 16.91T | 14.55T | 13.17T |
| Gross Profit | 4.39T | 4.66T | 4.41T | 3.33T | 2.98T | 2.73T |
| EBITDA | 1.68T | 2.12T | 2.50T | 1.64T | 2.36T | 2.08T |
| Net Income | 498.78B | 835.84B | 1.11T | 651.42B | 707.07B | 657.42B |
Balance Sheet | ||||||
| Total Assets | 32.85T | 30.78T | 29.77T | 24.67T | 23.97T | 21.92T |
| Cash, Cash Equivalents and Short-Term Investments | 5.03T | 4.74T | 5.18T | 4.07T | 3.89T | 3.05T |
| Total Debt | 13.55T | 4.42T | 10.08T | 7.62T | 8.05T | 6.74T |
| Total Liabilities | 20.07T | 18.15T | 16.77T | 13.17T | 13.20T | 12.55T |
| Stockholders Equity | 12.47T | 12.33T | 12.70T | 11.18T | 10.47T | 9.08T |
Cash Flow | ||||||
| Free Cash Flow | 11.83B | -555.28B | 138.61B | 1.50T | 1.23T | 521.24B |
| Operating Cash Flow | 816.57B | 292.15B | 747.28B | 2.13T | 1.68T | 1.07T |
| Investing Cash Flow | -840.87B | -941.97B | -867.27B | -678.06B | -376.06B | -796.88B |
| Financing Cash Flow | -145.77B | 280.48B | 918.65B | -1.47T | -615.72B | -283.98B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | $326.82B | 12.81 | 10.34% | 2.57% | 7.28% | 12.41% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
60 Neutral | $1.51T | 374.83 | 4.89% | ― | -2.93% | -47.22% | |
59 Neutral | $32.96B | 12.17 | 4.11% | 4.19% | 0.32% | -25.51% | |
57 Neutral | $70.29B | 24.08 | 4.34% | 0.69% | -1.29% | -49.96% | |
56 Neutral | $53.42B | -6.99 | -20.26% | 5.64% | 3.75% | 33.37% | |
55 Neutral | $17.75B | 29.41 | 6.53% | ― | -9.99% | -54.75% |